Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Conger

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Therapeutic Advances in Neurological Disorders|December 25, 2010
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosisElliot M Frohman, Gary Cutter, Gina Remington, et al.
Annals of Neurology|June 3, 2010
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosisLauren S Talman, Esther R Bisker, David J Sackel, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Therapeutic Advances in Neurological Disorders|December 25, 2010
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosisElliot M Frohman, Gary Cutter, Gina Remington, et al.
Annals of Neurology|June 3, 2010
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosisLauren S Talman, Esther R Bisker, David J Sackel, et al.
Pageof 3